157 related articles for article (PubMed ID: 31529157)
1. Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers.
Yavas Abali Z; Yesil G; Kirkgoz T; Cicek N; Alpay H; Turan S; Bereket A; Guran T
Pediatr Nephrol; 2020 Mar; 35(3):405-407. PubMed ID: 31529157
[No Abstract] [Full Text] [Related]
2. Rare cause of severe hypertension in an adolescent boy presenting with short stature: Questions.
Yavas Abali Z; Yesil G; Kirkgoz T; Cicek N; Alpay H; Turan S; Bereket A; Guran T
Pediatr Nephrol; 2020 Mar; 35(3):403-404. PubMed ID: 31529153
[No Abstract] [Full Text] [Related]
3. Type II pseudohypoaldosteronism. Report of a case and review of the literature.
Muhammad S; Mamish ZM; Tucci JR
J Endocrinol Invest; 1994 Jun; 17(6):453-7. PubMed ID: 7930391
[TBL] [Abstract][Full Text] [Related]
4. Dangerous hyperkalemia in a newborn: Answers.
Mittal A; Khera D; Vyas V; Choudhary B; Singh K
Pediatr Nephrol; 2019 May; 34(5):813-815. PubMed ID: 30382335
[No Abstract] [Full Text] [Related]
5. [Gordon syndrome: The importance of measuring blood pressure in children].
Bruel A; Vargas-Poussou R; Jeunemaitre X; Labbe A; Merlin E; Bessenay L
Arch Pediatr; 2016 Aug; 23(8):827-31. PubMed ID: 27369102
[TBL] [Abstract][Full Text] [Related]
6. A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3.
Tsuji S; Yamashita M; Unishi G; Takewa R; Kimata T; Isobe K; Chiga M; Uchida S; Kaneko K
BMC Nephrol; 2013 Jul; 14():166. PubMed ID: 23902721
[TBL] [Abstract][Full Text] [Related]
7. [Severity of familial hyperkalemic hypertension caused by CUL-3 mutations: a story about kidneys and blood vessels].
Rafael C; Hadchouel J
Med Sci (Paris); 2020 May; 36(5):455-458. PubMed ID: 32452365
[No Abstract] [Full Text] [Related]
8. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
Schweiger B; Moriarty MW; Cadnapaphornchai MA
Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
[TBL] [Abstract][Full Text] [Related]
9. Gordon syndrome caused by a
Park JH; Kim JH; Ahn YH; Kang HG; Ha IS; Cheong HI
J Pediatr Endocrinol Metab; 2022 Feb; 35(2):253-257. PubMed ID: 34480842
[No Abstract] [Full Text] [Related]
10. Familial Hyperkalemic Hypertension Genotype With a Negative Phenotype: A CUL3 Mosaicism.
Ostrosky-Frid M; Chávez-Canales M; Romo M; Grunfeld B; Simsolo R; Segura-Kato Y; Tusié-Luna T; Gamba G
Am J Hypertens; 2020 Mar; 33(3):278-281. PubMed ID: 31802109
[No Abstract] [Full Text] [Related]
11. Pseudohypoaldosteronism: report of a case presenting as failure to thrive.
Buzi F; Bezante T; Brunori A; Notarangelo LD; Ugazio AG
J Pediatr Endocrinol Metab; 1995; 8(1):61-5. PubMed ID: 7584700
[TBL] [Abstract][Full Text] [Related]
12. Pseudohypoaldosteronism Type II: A Young Girl Presented with Hypertension, Hyperkalemia and Metabolic Acidosis.
Sethar GH; Almoghawi A; Khan N; Altourah W; Ashour NM
J Coll Physicians Surg Pak; 2018 Mar; 28(3):S21-S22. PubMed ID: 29482694
[TBL] [Abstract][Full Text] [Related]
13. Hyperkalemia and hypertension: is this a "chloride-shunt" disorder?
Hirsch DJ
Clin Invest Med; 1990 Dec; 13(6):360-6. PubMed ID: 2078915
[No Abstract] [Full Text] [Related]
14. Renin-aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes.
Hanukoglu A; Edelheit O; Shriki Y; Gizewska M; Dascal N; Hanukoglu I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):268-74. PubMed ID: 18634878
[TBL] [Abstract][Full Text] [Related]
15. Cullin 3 and Blood Pressure Regulation: Insights From Familial Hyperkalemic Hypertension.
Maeoka Y; Cornelius RJ; McCormick JA
Hypertension; 2023 May; 80(5):912-923. PubMed ID: 36861484
[TBL] [Abstract][Full Text] [Related]
16. Familial hyperkalemic hypertension: hyperkalemia not hypertension defines dominant KLHL3 disease and may permit earlier recognition and tailored therapy.
Sambharia M; Gattineni J; Noureddine L; Mansilla MA; Thomas CP
J Nephrol; 2022 Jul; 35(6):1737-1742. PubMed ID: 35000137
[No Abstract] [Full Text] [Related]
17. Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension.
Sharma P; Chatrathi HE
Cell Commun Signal; 2023 Oct; 21(1):286. PubMed ID: 37845702
[TBL] [Abstract][Full Text] [Related]
18. [A case of mineralocorticoid-resistant renal hyperkalemia without sodium wasting (type II pseudohypoaldosteronism)].
Ito K; Yamada K; Hasunuma K; Shiina T; Ebata T; Kikuno K; Yoshida S; Tamura Y; Yoshida S
Nihon Naika Gakkai Zasshi; 1988 Mar; 77(3):425-9. PubMed ID: 3042897
[No Abstract] [Full Text] [Related]
19. Familial hyperkalemic hypertension (Gordon syndrome): evidence for phenotypic variability in a study of 7 families.
Disse-Nicodème S; Achard JM; Potier J; Delahousse M; Fiquet-Kempf B; Stern N; Blanchard A; Guilbaud JC; Niaudet P; Chauveau D; Dussol B; Berland Y; Dequiedt P; Ader JL; Paillard M; Grünfeld JP; Fournier A; Corvol P; Jeunemaitre X
Adv Nephrol Necker Hosp; 2001; 31():55-68. PubMed ID: 11692471
[No Abstract] [Full Text] [Related]
20. Pseudohypoaldosteronism: family studies to identify asymptomatic carriers by stimulation of the renin-aldosterone system.
Kuhnle U; Hinkel GK; Hubl W; Reichelt T
Horm Res; 1996; 46(3):124-9. PubMed ID: 8894667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
